In the worst-case scenario, getting chemicals in your eyes can lead to blindness. Until now, the eye irritancy potential of chemical substances has had to be assessed using the Draize test on live ...
In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...
As the pandemic escalated, in August 2020, the Trump administration Health and Human Services (HHS) directed the Food and Drug Administration (FDA) to stop requesting premarket approval for clinical ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation and permitted marketing for the first in vitro diagnostic test ...
Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...
Common Mistakes to Avoid in Order to Improve Translation of Interaction Data to the Clinic Since 2006, when the U.S. FDA published a draft guidance on drug interaction studies, it has expected new ...
The Lumipulse test measures the ratio of two specific beta-amyloid proteins in the cerebrospinal fluid, dubbed 1-42 and 1-40, that can accumulate in the brain and form plaques. (Getty Images) The FDA ...
The Food and Drug Administration has approved marketing for the first in vitro diagnostic test for early detection of Alzheimer’s disease. FDA PUTS NEW LIMITS ON JOHNSON & JOHNSON VACCINE DUE TO RARE ...
FDA recently permitted the marketing of the first in vitro diagnostic test for the early detection of amyloid plaques associated with Alzheimer’s disease. Adult patients aged 55 years and older being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results